China Health Group Inc. (FRA:VNL1)

Market Cap	15.45M -37.5%
Revenue (ttm)	3.54M +20.6%
Net Income	-1.57M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,000
Open	0.0055
Previous Close	0.0050
Day's Range	0.0055 - 0.0055
52-Week Range	0.0025 - 0.0300
Beta	n/a
RSI	44.76
Earnings Date	Mar 27, 2026

About China Health Group

China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers phar...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Employees: 44
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: VNL1

Financial Performance

In 2024, China Health Group's revenue was 26.45 million, an increase of 23.47% compared to the previous year's 21.43 million. Losses were -14.52 million, -74.97% less than in 2023.

Financial numbers in CNY